Clinical Trials Browser

Phase 1/2 × Central Nervous System Neoplasms × Sirolimus × Clear all

NCT00047073 2020-08-03

Sirolimus in Treating Patients With Glioblastoma Multiforme

Phase 1/2 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma